Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2026
Taletrectinib: First Approval.
Sheridan M Hoy
PubMed ↗
Publisher ↗
No numbers read from the abstract.
2 papers cite it
2026
this paper
cites it
Taletrectinib: First Approval. | OpenQuestion